SCHEMBL4187164

SCHEMBL4187164

CN1CCCC/C=C/C2CC2(C(=O)O)NC(=O)C(CCO[Si](C)(C)C(C)(C)C)NC1=O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CTSB P07858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4187161 1.00 CTSB (0.32) CTSB
SCHEMBL4187167 1.00 CTSB (0.32) CTSB
SCHEMBL13929764 0.90 — —
SCHEMBL13929827 0.85 CTSB (0.32) CTSB
SCHEMBL4187710 0.85 CTSB (0.33) CTSB
SCHEMBL4215396 0.85 CTSB (0.33) CTSB
SCHEMBL4204933 0.85 CTSB (0.33) CTSB
SCHEMBL4215391 0.85 CTSB (0.33) CTSB
SCHEMBL4204939 0.85 CTSB (0.33) CTSB
SCHEMBL4221020 0.82 CTSB (0.33) CTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029560-A2 1,3-OXAZOLIDIN-2-ONE DERIVATIVES USEEFUL AS CETP INHIBITORS Merck & Co., Inc. (US) 2009-03-04 — — EP disclosed
WO-2009014730-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2009-01-29 — — WO disclosed
WO-2007079186-A2 1, 3-OXAZOLIDIN-2-ONE DERIVATIVES USEFUL AS CETP INHIBITORS MERCK & CO., INC. (US) 2007-07-12 — — WO disclosed
Send feedback